Assessment of Device for Treatment of Amblyopia

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02003235

Enrollment

Registered

2013-12-06

Start date

2013-10-31

Completion date

2017-07-15

Last updated

2017-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia

Keywords

Amblyopia

Brief summary

The study will evaluate the effect of Reviview™, a dichoptic video display device for administrating a novel treatment protocol for Amblyopia (lazy eye) in kids. The effect of the treatment will be measured by the change from baseline in Visual acuity and in Stereoscopic Vision; and to assess the ease of use of and compliance by the patients.

Interventions

DEVICEDaily watching videos using Reviview™, a dichoptic video display device, for 60 min

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

4 Years to 8 Years

Healthy volunteers

Inclusion criteria

Refractive or Strabismic Amblyopia, with best corrected visual acuity. (1) Refractive Amblyopia, visual acuity score \<6:15 (worse then) * or (2) Strabismic Amblyopia, visual acuity score between 6:15 and 6:30

Exclusion criteria

Diagnosed with epilepsy, recently treated with occlusion or penalization therapy

Design outcomes

Primary

Measure	Time frame
Improvement in VA in amblyopic eye	3 months

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026